Dapsone indications and usage

Revision as of 22:21, 9 January 2014 by Chetan Lokhande (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Dapsone
DAPSONE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

INDICATIONS AND USAGE

Dermatitis herpetiformis

(D.H.)

Leprosy

All forms of leprosy except for cases of proven Dapsone resistance. [1]


References

  1. "DAPSONE TABLET [JACOBUS PHARMACEUTICAL COMPANY, INC.]".

Adapted from the FDA Package Insert.